BANK OF MONTREAL /CAN/ - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 158 filers reported holding INTERSECT ENT INC in Q4 2017. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2022$918,000
+931.5%
32,756
+640.6%
0.00%
Q1 2021$89,000
-52.9%
4,423
-48.1%
0.00%
Q4 2020$189,000
+626.9%
8,516
+465.1%
0.00%
Q3 2020$26,000
-44.7%
1,507
-41.9%
0.00%
Q2 2020$47,000
-51.0%
2,592
-32.5%
0.00%
Q4 2019$96,000
+108.7%
3,838
+42.5%
0.00%
Q3 2019$46,000
-22.0%
2,694
+4.6%
0.00%
Q2 2019$59,000
-96.6%
2,576
-95.3%
0.00%
-100.0%
Q1 2019$1,745,000
+8.5%
54,266
-5.0%
0.00%
-50.0%
Q4 2018$1,609,000
-13.7%
57,109
-11.9%
0.00%
+100.0%
Q3 2018$1,865,000
+10.7%
64,841
+44.2%
0.00%0.0%
Q2 2018$1,685,000
+897.0%
44,981
+947.0%
0.00%
Q1 2018$169,000
+25.2%
4,296
+2.7%
0.00%
Q4 2017$135,000
+159.6%
4,182
-17.1%
0.00%
Q4 2016$52,000
-18.8%
5,044
+24.8%
0.00%
Q3 2016$64,000
+1180.0%
4,042
+1419.5%
0.00%
Q1 2016$5,0002660.00%
Other shareholders
INTERSECT ENT INC shareholders Q4 2017
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 186,561$5,364,0004.51%
First Light Asset Management, LLC 517,121$14,867,0002.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,147,950$61,754,0002.21%
HealthCor Management, L.P. 1,950,000$56,063,0001.86%
PURA VIDA INVESTMENTS, LLC 200,000$5,750,0001.21%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 112,000$2,469,0001.17%
Broadfin Capital, LLC 234,200$6,733,0000.99%
Lombard Odier Asset Management (USA) Corp 240,000$6,900,0000.51%
PURA VIDA INVESTMENTS, LLC 83,527$2,401,0000.50%
Rock Springs Capital Management LP 460,000$13,225,0000.48%
View complete list of INTERSECT ENT INC shareholders